Table 4.
AAC | Cardiovascular events | All-cause mortality | ||
---|---|---|---|---|
HR (95%CI) | P | HR (95%CI) | P | |
(A) | ||||
Model 1 | ||||
Yes | 1.87 (1.23, 2.84) | 0.003 | 2.84 (1.73, 4.65) | <0.001 |
No | Reference | Reference | ||
Model 2 | ||||
Yes | 1.03 (0.67, 1.58) | 0.91 | 1.70 (1.01, 2.86) | 0.045 |
No | Reference | Reference | ||
Model 3 | ||||
Yes | 0.99 (0.64, 1.52) | 0.96 | 1.67 (0.99, 2.79) | 0.054 |
No | Reference | Reference | ||
CVC | Cardiovascular events | All-Cause Mortality | ||
HR (95%CI) | P | HR (95%CI) | P | |
(B) | ||||
Model 1 | ||||
Yes | 2.10 (1.38, 3.18) | <0.001 | 1.95 (1.10, 3.47) | 0.02 |
No | Reference | Reference | ||
Model 2 | ||||
Yes | 1.05 (0.68, 1.62) | 0.82 | 1.05 (0.58, 1.91) | 0.87 |
No | Reference | Reference | ||
Model 3 | ||||
Yes | 1.06 (0.69, 1.63) | 0.80 | 1.06 (0.58, 1.92) | 0.85 |
No | Reference | Reference |
Model 1 was univariate analysis, model 2 was adjusted for age and gender and model 3 was adjusted for age, gender, and eGFR.
CVC, cardiac valve calcification; eGFR, estimated glomerular infiltration rate; HR, hazard ratio; CI, confidence interval.